Thought I'd add an update. We are almost 5 months from diagnosis, which is a milestone some people with this cancer never see, yet we are acutely aware that 75% of these cases lead to death within 15 months of diagnosis.
After 3 cycles of chemotherapy, there was a really positive response shown on PET scan, with almost all of the lesions much less active than previously. That was really encouraging, and gave us all some hope. He had another cycle, then by agreement with the Dr we went back to UK to see family for a couple of weeks, which meant that the 5th cycle was going to be a week later than usual. We had a good time with friends and family and enjoyed the trip, but knew that he might not see most of these people again. Many of the people we met, even those that have been friends for more than 15 years, he chose not to tell about the cancer.
When we got back, he started to get increasingly unwell. There is a swollen, sore lymph node that we know is cancerous, and increasing fatigue, night sweats, loss of appetite, pain in groin, hip and back. Dr switched out one of the chemo meds as the genetic testing is still leaning more towards mesothelioma than anything else (but not confirmed, so will always be a mystery) and between the regimen change and checking out the lymph node, it was 6 weeks between cycles, hence the resurgence of symptoms. If it wasn't due to the delay, then it's due to resistance to chemotherapy, so not good news either way.
5 days on from the last infusion he's still super tired, very sore, taking morphine and oxycontin daily. The other issue he has is ultra sensitive, fragile skin and excessive bleeding. A teeny shaving cut or gentle head scratch leads to a constant trickle and a real challenge in healing. Yesterday morning he woke up to a pillowcase soaked in blood from the tiniest cut on his scalp. He's physically and emotionally exhausted, a bit snappy occasionally but I just let that go. I went back to work this week after 6 weeks off and I think he's struggling with being on his own again, too.